MedVentive, a Waltham, MA-based provider of population and risk management solutions for health plans and providers, completed a $12m Series D financing.
The round was led by new investors National Healthcare Services (NHS) and CHV II, LP, with participation from existing investors CHV Capital, Core Capital Partners, Excel Venture Management, HLM Venture Partners and Long River Ventures.
Led by President and CEO Nancy J. Ham, MedVentive offers a suite of business & clinical intelligence and outreach applications that support pay for performance programs, physician efficiency profiling and information-sharing, quality intervention, pharmacy management, and point-of-care decision support tools, which are all built on a risk-adjusted data foundation.
FinSMEs
26/10/2011